Positive impactCorporate Action
Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanza
Economic Times 1 hr ago·3 Nov 2026, 2:36 am
Rakesh Jhunjhunwala-backed pharma company has announced a 1:1 bonus issue, meaning shareholders will receive one additional share for every share they currently hold. This effectively doubles the number of shares an investor owns without any additional cost. The record date has been fixed, and the bonus shares will be credited to eligible demat accounts shortly after.
For retail investors, this announcement is significant as it increases the total shareholding and potentially improves liquidity. The bonus issue often signals management's confidence in the company's future growth and can boost market sentiment. However, it is crucial to remember that while the number of shares increases, the total value of the holding remains the same unless the stock price rises.
Investors should check their demat accounts to ensure they hold the shares before the record date. Since the settlement cycle is T+1, buying the stock on the last trading day is essential to qualify for the bonus. Investors should monitor the stock's price action and volume leading up to the record date to gauge market reaction.
Key takeaways
- Category: Corporate Action.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
